Review: Antiplatelet therapy prevents occlusive vascular events in high-risk patients

Asplund, Kjell
July 2002
ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p5
Academic Journal
Provides information on a study that explored how effective antiplatelet therapy is in patients at high risk for occlusive vascular events because of preexisting disease. Data sources; Study selection; Data extraction; Main results; Conclusion.


Related Articles

  • Bleeding, aspirin and clopidogrel. Aronson, Jeffrey // Pulse;4/15/2002, Vol. 62 Issue 15, p80 

    Addresses a question on the relative risks of bleeding for aspirin and clopidogrel in the treatment of stroke and myocardial infarction. Comparison between the effectivity of clopidogrel and aspirin; Effect of the combined clopidogrel and aspirin on several diseases; Risk of clopidogrel.

  • ACE inhibitor reduces cardiovascular events by 22%. Mayor, Susan // BMJ: British Medical Journal (International Edition);09/11/99, Vol. 319 Issue 7211, p661 

    Reveals that the risk of cardiovascular death, non-fatal myocardial infarction and stroke can be reduced by adding an angiotensin converting enzyme to standard care in patients at high risk of cardiovascular events. Information on a related study presented at the annual meeting of the European...

  • Antiplatelet Agents in the Treatment of ST-Segment Elevation Myocardial Infarction. Sinnaeve, Peter R.; Van de Werf, Frans J. // Current Medical Literature: Cardiology;2010, Vol. 29 Issue 2, p29 

    The article discusses the role of antiplatelet agents in managing patients with ST-segment elevation myocardial infarction (STEMI). Aspirin treatment is cited as a widely used antiplatelet agent which registered 23% reduction in mortality rates for myocardial infarction and 34% in stroke events....

  • Improving the process.  // Business North Carolina;Dec2006, Vol. 26 Issue 12, Special section p6 

    The article focuses on the innovations implemented by WakeMed Health & Hospitals in North Carolina to help ensure heart attack, stroke and medically fragile patients leave the hospital in the best possible condition. The Code STEMI program is designed for treating heart attack patients in which...

  • Magic bullet. Datta, Damayanti // India Today;5/ 4/2009, p24 

    The article presents information on a polypill created by a team of Indian doctors to fight heart attacks and stroke. On March 30, 2009, they unveiled a study about polypill at the American College of Cardiology in Orlando, Florida. The study was sponsored by Cadila Pharmaceuticals Ltd. and it...

  • Carbon monoxide -- a life saver?  // Process Engineering;Sep2005, Vol. 88 Issue 9, p9 

    Reports that researchers from the University of Michigan, Ann Arbor have studied the use of carbon monoxide (CO) to prevent rejection of transplanted organs and as a treatment for recovering stroke and heart attack victims. Research's finding that CO prevented inflammatory response in...

  • Small cells, big issues. Brass, Skip // Nature;1/11/2001, Vol. 409 Issue 6817, p145 

    Reports on the identification of the P2Y [sub12] receptor, a G protein-coupled ADP receptor on blood platelets. Role of ADP in activating platelets; Discussion of research published in this issue on the receptor's discovery; Relevance of this information, as is shown by the development of the...

  • The Heart of The Matter. Noonan, David // Newsweek;Fall/Winter2001 Special Edition, Vol. 138 Issue 11, p74 

    Examines cardiovascular disease (CVD) in the United States and the interventions which offer hopes of faster recovery and a better life. Statistics on CVD, which is the leading cause of death in the U.S.; Innovative approaches to the treatment of stroke and heart attack; Ways the disease can be...

  • Notable advances in the clinic.  // Nature Medicine;Dec2008, Vol. 14 Issue 12, p1303 

    The article reports on the efficacy of several drugs including statins, antihistamines, and losartan. It states that the drug statins is effective in preventing heart attacks and strokes. In Russia, a study revealed that a drug previously approved as antihistamine seem to improve the Alzheimer's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics